Operating Company Healthcare

CareMetx

Bethesda, Maryland, United States

Technology-enabled patient services partner providing high-touch support to accelerate patient initiation and adherence for specialty therapies. Uses proprietary digital benefit investigation intelligence and data-driven insights, combined with a skilled operations team, to improve speed and accuracy of patient access for specialty medications.

Focus Areas
Patient access services, Patient support programs, Patient hub services
Website
caremetx.com

Tracked deals

3

3 tracked deals across 2022-2026.

Recent pace

1

1 tracked deal announced in the last 12 months.

Deal mix

Buyout

3 buyout

CareMetx Acquisition Volume by Year

Last 3 years

Acquisition volume by year Annual acquisition counts for the last 3 years for CareMetx. 1 2022 1 2024 ~1 est. 1 2026
Actual Full-year estimate

Supporting Data

Recent Transactions

  • Buyer
    CareMetx, LLC
    Target
    Cencora, Inc.’s U.S. Hub consulting services operations (Lash Group) and TheraCom free goods pharmacy operations
    Seller
    Cencora, Inc.
    Location
    United States
    Type
    Buyout

    CareMetx acquired Cencora’s U.S. hub consulting services operations previously conducted under the Lash Group, including TheraCom free goods pharmacy operations. The deal expands CareMetx’s end-to-end patient access platform by adding full-service hub operations, patient access staffing infrastructure, and free goods pharmacy fulfillment.

  • Buyer
    CareMetx
    Target
    PX Technology
    Type
    Buyout

    CareMetx has acquired PX Technology to integrate PX's digital patient-access solutions (PX Connect, PX ePA, PX Consent) into CareMetx's hub services platform, aiming to speed and simplify access to specialty medications. The deal combines CareMetx's patient support services and manufacturer relationships with PX Technology's provider-focused digital tools and network of 1,300+ healthcare providers to improve provider workflows and patient treatment initiation.

  • Buyer
    CareMetx, LLC
    Target
    Human Care Systems, Inc.
    Location
    United States
    Type
    Buyout

    CareMetx, a technology-enabled hub services company focused on patient access to specialty medications, has acquired Human Care Systems (HCS) to add HCS's Resilix patient-adherence platform and services. The deal expands CareMetx's capabilities across the patient journey from initiation through adherence; HCS CEO Matt Hall will continue as President of HCS within the combined organization.

Related Acquisition Pages

Selling a company? Get in front of buyers like CareMetx

Turn tracked acquisition activity into an outreach-ready buyer list.